Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-22-016867
Filing Date
2022-09-14
Accepted
2022-09-14 16:26:47
Documents
60
Period of Report
2022-07-31

Document Format Files

Seq Description Document Type Size
1 10-Q organicellregen_10q.htm   iXBRL 10-Q 1207566
2 EXHIBIT 31.1 organicellregen_ex31-1.htm EX-31.1 18518
3 EXHIBIT 31.2 organicellregen_ex31-2.htm EX-31.2 17804
4 EXHIBIT 32.1 organicellregen_ex32-1.htm EX-32.1 6258
5 EXHIBIT 32.2 organicellregen_ex32-2.htm EX-32.2 6611
  Complete submission text file 0001829126-22-016867.txt   5456333

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ocel-20220731.xsd EX-101.SCH 47038
7 XBRL CALCULATION FILE ocel-20220731_cal.xml EX-101.CAL 46232
8 XBRL DEFINITION FILE ocel-20220731_def.xml EX-101.DEF 176152
9 XBRL LABEL FILE ocel-20220731_lab.xml EX-101.LAB 308412
10 XBRL PRESENTATION FILE ocel-20220731_pre.xml EX-101.PRE 271099
54 EXTRACTED XBRL INSTANCE DOCUMENT organicellregen_10q_htm.xml XML 793741
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 221243337
SIC: 3790 Miscellaneous Transportation Equipment